26
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      A Phase I Study of Gleevec (Imatinib Mesylate) Administered Concomitantly with Cytosine Arabinoside (Ara-C) in Patients with Philadelphia Positive Chronic Myeloid Leukemia (CML).

      Read this article at

      ScienceOpen
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Comments

          Comment on this article